Impact of SGLT2 Inhibitors in Heart Transplant Recipients

NCT06147271 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Transplant; Failure, Heart
Cardiac Allograft Vasculopathy
Rejection Heart Transplant

Interventions

DRUG: SGLT2i

Sponsor

Universidade Federal do Ceara

Collaborators

[object Object]